Emergent BioSolutions (EBS) Enterprise Value (2010 - 2026)
Emergent BioSolutions (EBS) reported Enterprise Value of $162.88 million for Q3 2026, down 25.7% from $219.31 million a year earlier and down 43.9% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Enterprise Value (2010 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Emergent BioSolutions' Enterprise Value came in at -$342.52 million; for FY2025, it was $438.56 million, up 4.5% from FY2024.
- Enterprise Value has a five-year compound annual growth rate of -36.2% (FY2020 to FY2025).
- By year, Enterprise Value came in at $419.61 million in FY2024, $13.58 million in FY2023, -$50.92 million in FY2022 and $1.65 billion in FY2021 (-60.0%).
- The Q3 2026 figure ranks as the lowest quarterly Enterprise Value since Q2 2025.
- Year over year, Enterprise Value gained in four of the last seven quarters, with growth averaging 58.5%.
- The high point for year-over-year Enterprise Value in five years was Q2 2026 (growth of 285.4%); the low point was Q1 2023 (a decline of 94.4%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $290.19 million (Q2 2026), $269.64 million (Q1 2026) and $438.56 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 162.88 Mn |
| Jun 30, 2026 | 290.19 Mn |
| Mar 31, 2026 | 269.64 Mn |
| Dec 31, 2025 | 438.56 Mn |
| Sep 30, 2025 | 219.31 Mn |
| Jun 30, 2025 | 75.31 Mn |
| Mar 31, 2025 | 115.77 Mn |
| Dec 31, 2024 | 419.61 Mn |
| Sep 30, 2024 | 301.84 Mn |
| Jun 30, 2024 | 291.08 Mn |
| Mar 31, 2024 | 54.07 Mn |
| Dec 31, 2023 | 13.58 Mn |
| Sep 30, 2023 | 88.32 Mn |
| Jun 30, 2023 | 292.13 Mn |
| Mar 31, 2023 | 91.94 Mn |
| Dec 31, 2022 | -50.92 Mn |
| Sep 30, 2022 | 806.50 Mn |
| Jun 30, 2022 | 1.19 Bn |
| Mar 31, 2022 | 1.63 Bn |
| Dec 31, 2021 | 1.65 Bn |
API Access
Emergent BioSolutions Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();